Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)

被引：44

作者：

Froment, Pascal ^{[1
]}

Touraine, Philippe ^{[2
]}

机构：

[1] Hop Debrousse, UMR Commun Cellulaire & Differenciat, INSERM, Unite 418, F-69322 Lyon, France

[2] GH Pitie Salpetriere, Dept Endocrinol & Reprod Med, F-75651 Paris 13, France

来源：

PPAR RESEARCH | 2006年 / 2006卷

关键词：

D O I：

10.1155/PPAR/2006/73986

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Polycystic ovary syndrome (PCOS) is the most frequent cause of female infertility. The treatment of PCOS patients with insulin sensitizers, such as metformin or thiazolidinediones, increases the ovulation rate and the number of successful pregnancies. The positive action of the insulin-sensitizing treatments could be explained by a decrease in the peripheral insulin resistance but also by a direct action at the ovarian level. We report in this review different hypotheses of thiazolidinediones actions to improve PCOS (steroid secretion by ovarian cells; insulin sensitivity in muscle and adipocyte and fat redistribution). Copyright (C) 2006 P. Froment and P. Touraine.

引用

页数：8

共 100 条

[1] Troglitazone suppresses cell growth of KU812 cells independently of PPAR-γ [J].

Abe, A ;

Kiriyama, Y ;

Hirano, M ;

Miura, T ;

Kamiya, H ;

Harashima, H ;

Tokumitsu, Y .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 436 (1-2) :7-13

[2] The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones [J].

Arner, P .

TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2003, 14 (03) :137-145

[3]

AVTANSKI D, 2006, P 88 ANN M END SOC E

[4] Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial [J].

Azziz, R ;

Ehrmann, D ;

Legro, RS ;

Whitcomb, RW ;

Hanley, R ;

Fereshetian, AG ;

O'Keefe, M ;

Ghazzi, MN .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1626-1632

[5] Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity [J].

Baillargeon, JP ;

Jakubowicz, DJ ;

Iuorno, MJ ;

Jakubowicz, S ;

Nestler, JE .

FERTILITY AND STERILITY, 2004, 82 (04) :893-902

[6] MISCARRIAGE RATES FOLLOWING INVITRO FERTILIZATION ARE INCREASED IN WOMEN WITH POLYCYSTIC OVARIES AND REDUCED BY PITUITARY DESENSITIZATION WITH BUSERELIN [J].

BALEN, AH ;

TAN, SL ;

MACDOUGALL, J ;

JACOBS, HS .

HUMAN REPRODUCTION, 1993, 8 (06) :959-964

[7] PPARγ is required for placental, cardiac, and adipose tissue development [J].

Barak, Y ;

Nelson, MC ;

Ong, ES ;

Jones, YZ ;

Ruiz-Lozano, P ;

Chien, KR ;

Koder, A ;

Evans, RM .

MOLECULAR CELL, 1999, 4 (04) :585-595

[8] Pathophysiology of ovarian steroid secretion in polycystic ovary syndrome [J].

Barnes, RB .

SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1997, 15 (02) :159-168

[9]

BATES GW, 1982, FERTIL STERIL, V38, P406

[10] Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome [J].

Belli, SH ;

Graffigna, MN ;

Oneto, A ;

Otero, P ;

Schurman, L ;

Levalle, OA .

FERTILITY AND STERILITY, 2004, 81 (03) :624-629

← 1 2 3 4 5 6 7 8 9 10 →